MUSELLA, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 1.494
AS - Asia 1.167
EU - Europa 192
Continente sconosciuto - Info sul continente non disponibili 30
AF - Africa 16
SA - Sud America 6
OC - Oceania 5
Totale 2.910
Nazione #
US - Stati Uniti d'America 1.263
TR - Turchia 470
CN - Cina 353
SG - Singapore 310
CA - Canada 231
IT - Italia 115
EU - Europa 28
DE - Germania 27
HK - Hong Kong 22
SC - Seychelles 13
IE - Irlanda 11
RU - Federazione Russa 8
SE - Svezia 6
AU - Australia 4
CH - Svizzera 4
FI - Finlandia 4
NL - Olanda 4
IN - India 3
JP - Giappone 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
EG - Egitto 2
ES - Italia 2
GB - Regno Unito 2
IR - Iran 2
UA - Ucraina 2
AT - Austria 1
BG - Bulgaria 1
BR - Brasile 1
CL - Cile 1
CO - Colombia 1
EC - Ecuador 1
FR - Francia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
KW - Kuwait 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
ZA - Sudafrica 1
Totale 2.910
Città #
San Mateo 448
Kocaeli 401
Toronto 225
Wilmington 113
Santa Clara 99
Singapore 97
Houston 83
Lawrence 78
Princeton 78
Beijing 64
Chandler 54
Shanghai 41
Ashburn 37
Rome 36
Los Angeles 26
Guangzhou 23
Hong Kong 20
Fairfield 18
Seattle 17
Woodbridge 16
Shenzhen 14
West Jordan 10
Falls Church 9
Cambridge 8
Jiaxing 7
Rui'an 6
Wuxi 6
Dallas 5
Milan 5
Viggiù 5
Xi'an 5
Council Bluffs 4
Helsinki 4
Palermo 4
Redwood City 4
Wuhan 4
Bern 3
Boardman 3
Dongyang 3
Florence 3
Kemerovo 3
Lariano 3
Pune 3
Taizhou 3
Xuzhou 3
Al Qahirah al Jadidah 2
Alessandria 2
Andover 2
Bengbu 2
Berlin 2
Chengdu 2
Città di Castello 2
Dublin 2
Hobart 2
Jinan 2
Las Vegas 2
Moscow 2
Nanchang 2
Pistoia 2
Salt Lake City 2
The Dalles 2
Washington 2
Abano Terme 1
Amsterdam 1
Auckland 1
Basra 1
Brampton 1
Brooklyn 1
Brownsburg 1
Budapest 1
Cagliari 1
Cangzhou 1
Cassino 1
Changchun 1
Changsha 1
Charlotte 1
Chattanooga 1
Dalian 1
Des Moines 1
Dongguan 1
Easley 1
Foshan 1
Frankfurt am Main 1
Fremont 1
Fuzhou 1
Gander 1
Geislingen an der Steige 1
Glasgow 1
Greater Sudbury 1
Guiyang 1
Haining 1
Hefei 1
Islamabad 1
Jinhua 1
Jiyuan 1
Kharkov 1
Kiryat Ono 1
Kunshan 1
Kuwait City 1
La Paz 1
Totale 2.173
Nome #
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis 58
4-Aminopyridine derivatives with anticholinesterase and antiamnesic activity 57
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis 56
'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting 53
Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis 52
Linking synaptopathy and gray matter damage in multiple sclerosis 50
Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum 50
GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis 48
Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis 48
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter 48
Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions 47
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome 47
Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis 46
Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis. 45
Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis 44
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis 44
A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum 44
A Dynamic Splicing Program Ensures Proper Synaptic Connections in the Developing Cerebellum 44
Il-1β Dependent Cerebellar Synaptopathy in a Mouse Mode of Multiple Sclerosis 43
TNF-α-mediated anxiety in a mouse model of multiple sclerosis 42
Behavioral and electrophysiological effects of endocannabinoid and dopaminergic systems on salient stimuli 42
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis 42
Interleukin-1β promotes long-term potentiation in patients with multiple sclerosis 41
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA 41
Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis 40
Caffeine drinking potentiates cannabinoid transmission in the striatum: interaction with stress effects 40
Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis 39
Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity 39
Obesity worsens central inflammation and disability in multiple sclerosis 39
Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination 39
Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis 38
Before or after does it matter? Different protocols of environmental enrichment differently influence motor, synaptic and structural deficits of cerebellar origin 38
Adaptations of striatal endocannabinoid system during stress 38
Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis 38
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 38
Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis 37
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum 37
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis 37
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis 37
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis 36
TRPV1 channels facilitate glutamate transmission in the striatum 36
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis 36
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum 35
MiR-142-3p is a key regulator of IL-1β-dependent synaptopathy in neuroinflammation 35
Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons 35
Re-Examining the Role of TNF in MS Pathogenesis and Therapy 35
Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum 34
The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission 34
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 34
Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake 34
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients 34
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 33
Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis 33
Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum 33
Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study 32
Cerebellar control of cortico-striatal LTD 32
Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity 32
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 31
Adaptations of glutamatergic synapses in the striatum contribute to recovery from cerebellar damage 31
Differences in spontaneously avoiding or approaching mice reflect differences in CB1-mediated signaling of dorsal striatal transmission 31
Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation 31
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis 29
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 29
Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum 29
Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis 29
Interleukin-1β causes anxiety by interacting with the endocannabinoid system 28
Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis 28
Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis 28
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 28
Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis 27
Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum 27
Effects of caffeine on striatal neurotransmission: focus on cannabinoid CB1 receptors 27
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis 26
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis 22
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 20
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 20
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis 18
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis 18
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 16
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 16
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis 15
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 14
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis 14
Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis 13
Preventive exercise and physical rehabilitation promote long‐term potentiation‐like plasticity expression in patients with multiple sclerosis 12
Electrophysiology of Endocannabinoid Signaling 11
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis 10
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis 8
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation 8
Interaction between miR-142-3p and BDNF Val/Met Polymorphism Regulates Multiple Sclerosis Severity 7
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis 7
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis 7
Special Issue Title: The neuroimmune crosstalk in mood disturbances of neurological and psychiatric diseases 7
Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis 7
Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression 7
Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients 7
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis 7
Totale 3.069
Categoria #
all - tutte 34.931
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.931


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202079 0 0 0 0 0 0 0 0 0 0 43 36
2020/2021650 48 34 5 1 27 25 33 9 16 13 403 36
2021/2022871 2 222 232 4 6 8 34 92 20 226 19 6
2022/2023306 179 4 4 19 8 14 0 9 10 19 23 17
2023/2024226 4 6 8 41 6 14 1 12 0 37 0 97
2024/2025831 50 160 103 56 37 145 65 48 145 22 0 0
Totale 3.069